Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Psilocybin and Obsessive Compulsive Disorder.

James Allen Wilcox¹

¹a Professor of Clinical Psychiatry , University of Arizona , Tucson , AZ.

Journal of Psychoactive Drugs

|November 4, 2014

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical implications of co-occurring prolonged grief disorder in patients with treatment-resistant major depressive disorder.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2021

Same author

The Syndrome of Catatonia.

Behavioral sciences (Basel, Switzerland)·2015

Same author

Movement disorders and MDMA abuse.

Journal of psychoactive drugs·2009

Same journal

Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study.

Journal of psychoactive drugs·2026

Same journal

Cannabis-Induced Persistent Perceptual Disturbances: A Clinical Characterization Study of Multimodal Sensory Symptoms in 13 Patients.

Journal of psychoactive drugs·2026

Same journal

Specialist Inpatient Detoxification from Gabapentinoids: Clinical and Demographic Characteristics and Predictors of Outcome.

Journal of psychoactive drugs·2026

Same journal

Urine Prevalence of Psychoactive Substances, Nicotine Exposure and Associated Factors Among Commercial Drivers. An Exploratory Study.

Journal of psychoactive drugs·2026

Same journal

Latent Clusters of Peer Behaviors in Childhood and Relevance for Understanding Substance Use in Early Adolescence.

Journal of psychoactive drugs·2026

Same journal

Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.

Journal of psychoactive drugs·2026

See all related articles

Psilocybin, a compound affecting serotonin, was used by one individual to successfully reduce Obsessive Compulsive Disorder (OCD) symptoms for years. This case highlights the potential role of serotonin in OCD and suggests further research into psilocybin for anxiety disorders.

Area of Science:

Neuroscience
Psychiatry

Background:

Obsessive Compulsive Disorder (OCD) is a debilitating psychiatric condition with significant morbidity and mortality.
Many individuals with OCD experience treatment-refractory symptoms, necessitating novel therapeutic approaches.

Observation:

A case study explored the use of psilocybin, a known serotonergic agent, in an individual with OCD.
The individual reported sustained reduction in core OCD symptoms over several years following psilocybin use.

Findings:

The successful long-term reduction of OCD symptoms suggests a potential role for serotonergic pathways in the disorder.
Psilocybin's efficacy in this case warrants further investigation into its therapeutic potential for OCD.

Implications:

Keywords:

anxiety obsessive compulsive psilocybin psychedelic

Related Experiment Videos

This case underscores the importance of serotonergic mechanisms in OCD pathophysiology.
Further rigorous research into psilocybin as a treatment for anxiety disorders, including OCD, is indicated.